: A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric buy Blebbistatin Cancer diagnosis. Eur J Cancer
2011, 47:784–791.PubMedCrossRef 84. Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, Wang MX: Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 2011, 4:575–586.PubMed 85. Schrauder MG, Strick R, Schulz-Wendtland R, Batimastat in vitro Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, et al.: Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012, 7:e29770.PubMedCrossRef 86. Bianchi F, Nicassio F, Marzi M, Belloni E: Dall’olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G, Di Fiore PP: A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 2011, 3:495–503.PubMedCrossRef 87. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, et al.: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival AG-120 order of non-small-cell lung cancer. J Clin Oncol 2010, 28:1721–1726.PubMedCrossRef 88. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W: Circulating plasma MiR-141 is a novel
biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011, 6:e17745.PubMedCrossRef 89. Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY: Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010, 25:1674–1680.PubMedCrossRef 90. Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, Dai B, Zhu YP, Shen YJ, Shi GH, Ye DW: Serum miRNA-21: elevated levels in patients with Carnitine palmitoyltransferase II metastatic hormone-refractory prostate
cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 2011, 71:326–331.PubMedCrossRef 91. Kroh EM, Parkin RK, Mitchell PS, Tewari M: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50:298–301.PubMedCrossRef 92. Heneghan HM, Miller N, Kerin MJ: Circulating miRNA signatures: promising prognostic tools for cancer. J Clin Oncol 2010, 28:e573–574. author reply e575–576PubMedCrossRef 93. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A: Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011, 57:833–840.PubMedCrossRef 94. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, et al.: Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009, 81:717–729.PubMedCrossRef 95.